查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2022-2029 年语音重建设备的全球市场
市场调查报告书
商品编码
1153811

2022-2029 年语音重建设备的全球市场

Global Voice Restoration Devices Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

语音重建设备的全球市场预计将在 2021 年达到 5.3129 亿美元，在 2029 年达到 6.0275 亿美元，在预测期内（2022-2029 年）以 9.58% 的复合年增长率增长。

语音重建设备与食管语音和拇指造口阻塞等语音疗法结合使用，以帮助喉切除术患者恢復语音。在许多情况下，喉癌会导致声带被切除。在这种情况下，您将需要使用设备或植入物进行特定的声音恢復治疗。

市场动态

对这些语音恢復设备的需求增加、喉癌发病率上升、研发支出增加以及新产品推出的增加预计将推动市场增长。

新产品的推出和对语音重建设备不断增长的需求将推动市场增长。

语音重建设备的全球市场主要受到医疗保健行业语音重建设备需求激增、产品发布数量增加以及这些电子喉的诸多好处的推动。已经对有利于语音恢復的新型微创耳鼻喉手术进行了各种研究。例如，2021年10月，开发Blom-Singer语音恢復等耳鼻喉产品的InHealth Technology宣布推出Blom-Singer Speak free HME免提阀。该产品将使接受全喉切除术的患者受益。

随着各种最新的创新，语音重建设备的数量不断增加，需求也越来越大。这些设备的最新创新正在推动市场的增长。例如，Orvisana Healthcare 的 Servox Digital XL Electrolarynx 是一种人工声带设备，可通过复製声带的活动来放大语音。对接受过气管切开手术的人有效。可以通过设置更改音量和频率。

与语音重建设备相关的高成本阻碍了市场的增长。

然而，设备和程序的高成本会抑制市场潜力。市场上有各种类型的音频助听器和方法。由于预算不足，许多中小型诊所无法订购和预付各种品牌和尺寸的最小库存设备。气动喉装置的价格从大约 75 美元到 150 美元不等，颈式电子喉装置的价格从 150 美元到 800 美元不等。

COVID-19 影响分析

疫情对全球金融预期、运营和危机应对策略产生了负面影响。市场进入者正在改变他们的长期和短期增长战略，利用研究市场创造尖端项目来对抗这一流行病。即使 COVID-19 损害了行业，重要的是要为您的业务运营製定并儘快制定备份计划。世界各地正在进行各种合作和合併，推动了市场的增长。例如，2022 年 1 月，ICU Medical 收购了医疗器械製造商 Smith's Medical。

内容

第 1 章市场研究方法和范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第四章市场动态

  • 市场影响因素
    • 司机
      • 新产品发布次数增加
      • 对语音重建设备的需求增加
    • 约束因素
      • 与这些设备相关的高成本
    • 商机
    • 影响分析

第五章行业分析

  • 搬运工的五种力量
  • 未满足的需求
  • 供应链分析
  • 监管分析

第 6 章 COVID-19 分析

  • COVID-19 市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按设备类型

  • 人工喉（电子喉）
  • 用于气管食管的人工声带
    • Probox 人工声带
    • Blomsinger 假肢
    • Nydam 人工声带
    • 格罗宁根语音假体

第 8 章按产品寿命分类

  • 12 个月或更长时间
  • 6 到 12 个月
  • 少于 6 个月

第 9 章最终用户

  • 多学科医院
  • 耳鼻喉科医院
  • 门诊手术中心

第10章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第11章竞争格局

  • 主要发展和战略
  • 公司股票分析
  • 产品基准
  • 值得关注的主要公司名单

第12章公司简介

  • Atos Medical（Coloplast）
    • 公司概况
    • 产品组合和说明
    • 主要亮点
    • 财务摘要
  • Inhealth Technologies
  • Freudenberg Medical
  • Luminaud Inc.
  • Romet Electronic Larynx
  • Smith's Medical（ICU Medical）
  • Sanova Holding AG
  • Orbisana Healthcare
  • Acclarent Inc.（Johnson & Johnson）
  • William Demant Holdings

第13章 声音重建设备的全球市场-DataM

简介目录
Product Code: DMMD689

Market Overview

The global voice restoration devices market was valued at US$ 531.29 million in 2021 and is estimated to reach US$ 602.75 million by 2029, growing at a CAGR of 9.58% during the forecast period (2022-2029).

Voice restoration devices are used with voice therapy, such as esophageal speech and stoma occlusion with the thumb, to help laryngectomy patients produce a statement. In most cases, the voice box is removed due to larynx cancer. The patient has to undergo specific voice restoration therapy involving devices and implants.

Market Dynamics

The increasing demand for these voice restoration devices, the rising incidence of larynx cancer, the increasing research and development expenditure and growth in novel product launches are expected to drive market growth.

The increasing novel product launches and demand for voice restoration devices will drive market growth.

The global market for voice restoration devices is primarily driven by the surge in demand for voice restoration devices in the healthcare industry, the rising number of product launches, and the many advantages of these electrolarynxes. Various studies are being conducted on novel minimally invasive ENT procedures that benefit voice restoration. For instance, in Oct 2021, InHealth Technology, a company that develops ENT products such as Blom-Singer voice restoration, announced the launch of the Blom-Singer Speak free HME hands-free valve. This product will be advantageous for patients who have undergone total laryngectomy.

Various latest technological advancements are taking place, and the number of voice restoration device launches is increasing, increasing the demand. The latest innovations in these devices are driving the growth of the market. For instance, Orbisana Healthcare's product Servox Digital XL electrolarynx is a voice prosthesis device that copies the activity of the voice box and amplifies the speech. It can be useful for individuals got tracheotomy procedures. Volume and frequency can be changed from settings.

High costs associated with voice restoration devices will hamper the market's growth.

However, the high cost of devices and procedures might hamper the market potential. Various types of voice prostheses and methods are available in the market. Many small and medium-sized clinics cannot order and prepay for a minimum stock of different brands and sizes of devices due to a lack of budget. The price of pneumatic artificial larynx devices ranges from approximately USD 75 to USD 150, while the neck-type electrolarynx device's price varies from USD 150 to USD 800.

COVID-19 Impact Analysis

The pandemic has negatively impacted global financial expectations, operations and crisis response strategy. Market participants are changing their long-term and short-term growth strategies by utilizing the research market and creating cutting-edge items to combat the pandemic. Even though COVID-19 harms the industry, preparing and implementing backup plans as soon as possible for business operations is crucial. Various collaborations and mergers are happening worldwide, boosting the market's growth. For instance, in Jan 2022, ICU Medical acquired Smith's Medical, a medical device manufacturer.

Segment Analysis

The artificial larynx (Electrolarynx) segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The artificial larynx (Electrolarynx) segment is the highest market holder in the global voice restoration devices market. The artificial larynx (Electrolarynx) is the leading device type in the market, holding a dominant share. Electrolarynx is a vibrator that is externally operated and is placed on the chin or cheeks; that generates vibrations in the throat that are further converted into speech from the mouth of the patient. A significant advantage of the artificial larynx is that its use is often quickly and rapidly learned and is now available latest hand-free devices. The devices, specifical valves, are made of silicone in voice prosthesis and electronically operated devices in an electrolarynx. According to the NIH, in 2021, larynx cancer caused approximately 0.6% of deaths and 0.7% of new cases of all cancers globally. The novel development of innovative and advanced electrolarynx is increasing market growth. For instance, Romet Electronic Larynx introduced its Romet R700 Clarity programmable digital electronic larynx. It is a digital electrolarynx device that laryngectomy patients use. This digital device produces some mechanical vibrations having a low sound frequency of around 60-195 Hz. In the neck, these vibrations develop trembling in the oral cavity, which is the same as the human voice. Combining the starting and stopping sound vibrations with oral articulation generates human speech.

Geographical Analysis

North America holds the largest market share of the global voice restoration devices market.

North America dominates the global voice restoration devices market, primarily attributed to the increasing number of partnerships or collaborations between companies, the rising demand for voice restoration devices, and novel studies. Furthermore, factors including growing expenditure on research and development, the increasing incidence of laryngeal and hypopharyngeal cancer, and the adoption of voice restoration devices among patients will likely enhance the growth of the region's voice restoration devices market. The American Cancer Society estimated that about 12,470 new laryngeal cancer cases would be registered in the U.S. in 2022, out of which 3,820 people are expected to die from laryngeal cancer.

Moreover, the growing number of product launches is responsible for the market's growth. Other factors, such as the high spending of GDP on healthcare, stimulate the market's growth. Many key developments and technological advancements are taking place based in this region. For instance, in Sep 2021, Acclarent Inc, a subsidiary of Johnson & Johnson company of medical devices, developed minimally invasive ENT technologies and launched its AI-powered ENT technology. This technology simplifies surgical planning, and it provides real-time feedback during ENT navigation procedures.

Competitive Landscape

The voice restoration devices market is highly competitive with local and global companies. Atos Medical, Inhealth Technologies, Freudenberg Medical, Luminaud Inc., Romet Electronic Larynx, Smith's Medical (ICU Medical), Sanova Holding AG, Orbisana Healthcare, Acclarent Inc. (Johnson & Johnson), William Demant Holdings and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, in Oct 2022, Coloplast completed the acquisition of Atos Medical, an innovative medical device developer in laryngectomy and tracheostomy, after receiving the regulatory authority's approval. This will lead to the addition of new ENT and Respiratory care in Coloplast's business segment.

Atos Medical (Coloplast):

Overview:

Atos Medical is a company that designs and commercializes innovative medical devices in laryngectomy and tracheostomy. It was founded in 1986 and is headquartered in Malmo, Sweden. Atos provides its products in around 90 countries.

Product Portfolio:

Provox ActiValve: It is a prosthesis device specially developed for patients facing early leakage problems from voice prostheses. The valve flap and ring are fluoroplastic material that prevents candida destruction. While breathing and swallowing, the inadvertent opening of the valve flap will be prevented by the magnets.

The global voice restoration devices market report would provide access to approximately 40+ market data tables, 45+ figures, and 200 (approximate) pages.

Table of Contents

1. Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The rising novel product launches
      • 4.1.1.2. Increasing demand for voice restoration devices
    • 4.1.2. Restraints:
      • 4.1.2.1. High cost associated with these devices
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces
  • 5.2. Unmet Needs
  • 5.3. Supply chain Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Device Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 7.1.2. Market Attractiveness Index, By Device Type
  • 7.2. Artificial Larynx (Electrolarynx) *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Tracheoesophageal Voice Prosthesis
    • 7.3.1. Provox Voice Prosthesis
    • 7.3.2. Blom-Singer Prosthesis
    • 7.3.3. Nijdam Voice Prosthesis
    • 7.3.4. Groningen Voice Prosthesis

8. By Device Lifespan

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Lifespan
    • 8.1.2. Market Attractiveness Index, By Device Lifespan
  • 8.2. More than 12 Months *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. 6-12 Months
  • 8.4. Less than 6 Months

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Multi-Specialty Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. ENT Hospitals
  • 9.4. Ambulatory Surgical Centres

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Lifespan
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), End-User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. The U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Lifespan
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), End-User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. The U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Lifespan
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), End-User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Lifespan
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), End-User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Lifespan
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), End-User
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country

11. Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Product Benchmarking
  • 11.4. List of Key Companies to Watch

12. Company Profiles

  • 12.1. Atos Medical (Coloplast)
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Inhealth Technologies
  • 12.3. Freudenberg Medical
  • 12.4. Luminaud Inc.
  • 12.5. Romet Electronic Larynx
  • 12.6. Smith's Medical (ICU Medical)
  • 12.7. Sanova Holding AG
  • 12.8. Orbisana Healthcare
  • 12.9. Acclarent Inc. (Johnson & Johnson)
  • 12.10. William Demant Holdings

LIST NOT EXHAUSTIVE

13. Global Voice Restoration Devices Market- DataM

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us